New Article information at Pharmaceutical Technology New and updated information from Article listed on en-us New Article information at Pharmaceutical Technology Imaging Centre of Excellence, University of Glasgow, Scotland The Imaging Centre of Excellence (ICE) at the Queen Elizabeth University Hospital (QEUH) in Scotland was inaugurated in March 2017. Wed, 26 Jul 2017 23:00:00 GMT PhRMA: resetting the conversation Over the last few years, the issue of drug prices has been rising ever higher on the agenda in the US. Prominent politicians, including former democratic presidential hopeful and champion of American socialism Bernie Sanders, have campaigned hard to … Tue, 25 Jul 2017 23:00:00 GMT Do healthcare cuts risk creating a ‘desert for innovation’ in the UK? The world’s biggest drug companies could reconsider their operations in the UK if the country’s new Government doesn’t increase its spending on NHS treatments and patient access to new medicines, according to the Association of the British Pharmaceut… Sun, 23 Jul 2017 23:00:00 GMT Takeda Pharmaceutical’s Manufacturing Facility, Oranienburg Japanese drug maker, Takeda Pharmaceutical Company, inaugurated a new pharmaceutical production facility at its existing site in Oranienburg town, Brandenburg, Germany, in June 2017. Thu, 20 Jul 2017 23:00:00 GMT Betting big on Gamma Delta T Cells Gamma Delta T Cells live in our tissue and form a crucial part of our immune system. Until recently, they have been on the sidelines of cancer research, but a $100m cash injection from drug giant Takeda Pharmaceuticals into a small biotech firm with … Thu, 20 Jul 2017 09:27:00 GMT Pharma Technology Focus – Issue 61 In this issue: The UK’s healthcare spending problem, PhRMA’s new R&D spending requirements, undermining supply chain security by importing foreign drugs, milestone cystic fibrosis trials, a personalised treatment approach for panic disorder, and more… Wed, 19 Jul 2017 13:55:00 GMT Cystic fibrosis: searching for a breakthrough There are exciting years ahead for the treatment of cystic fibrosis (CF). This inherited autosomal recessive genetic disorder has proven to be incredibly tough for drug developers, with research efforts hampered by the formidable scientific challenge… Tue, 18 Jul 2017 23:00:00 GMT US drug imports: a recipe for disaster? Many in the US are weighing up whether importing drugs from foreign markets would be a good way to improve patient access to medication. Sun, 16 Jul 2017 23:00:00 GMT Huntsman Cancer Institute Expansion, Utah The Huntsman Cancer Institute (HCI) is a part of the University of Utah campus in Salt Lake City, US. Thu, 13 Jul 2017 23:00:00 GMT Treating mononucleosis: why the mystery? Often abbreviated to 'mono', Mononucleosis is a common viral infection that affects hundreds of thousands of people each year. It is generally caused by the Epstein-Barr virus (EBV), which is one of the most common human viruses in the world. The con… Wed, 12 Jul 2017 23:00:00 GMT Takeda Pharmaceutical’s High-Containment Production Facility, Grange Castle, Dublin Japan-based pharmaceutical company Takeda has initiated construction of a new high-containment production facility at its existing site in Grange Castle Business Park in Dublin, Ireland. Wed, 12 Jul 2017 23:00:00 GMT Reforming paediatric cancer trials in Europe Cancer experts are calling on European officials to reform outdated rules on clinical trials that allow pharmaceutical companies to opt out of testing new cancer drugs in children even where there is good evidence they could be beneficial. Sun, 09 Jul 2017 23:00:00 GMT Immuno-oncology: where to go in a packed field Over the last decade or so, immuno-oncology has gained a reputation as one of the most exciting areas in medicine. Referring to treatments that harness the immune system in the fight against cancer, it has grown from a niche and somewhat speculative … Wed, 05 Jul 2017 23:00:00 GMT June's top stories: Takeda and Biological E. collaborated, J&J completed Actelion acquisition Takeda and Biological E. collaborated to develop affordable combination vaccines, and J&J completed the Actelion acquisition for $30bn. wraps up the key headlines from June. Tue, 04 Jul 2017 23:00:00 GMT Hanmi Pharmaceutical's New Bio Manufacturing Plant, Pyeongtaek Hanmi Pharmaceutical is constructing a new biologics manufacturing facility in the city of Pyeongtaek in the Gyeonggi province of South Korea. Tue, 04 Jul 2017 23:00:00 GMT Pfizer R&D Facility, Chesterfield, Missouri US-based biopharmaceutical company Pfizer began the construction of a new research and development (R&D) laboratory and office facility in Missouri, US, in June 2017. Sun, 02 Jul 2017 23:00:00 GMT Roundtable: discussing trends in contract manufacturing As outsourced contract manufacturing continues to grow, the need for a trustworthy partner is paramount. Business development director at Idifarma Manuel Leal Sanchez, vice-president of manufacturing services and head of corporate social responsibili… Sun, 02 Jul 2017 23:00:00 GMT Virginia Cancer Specialists (VCS) Research Facility, Virginia Virginia Cancer Specialists (VCS) opened a phase I clinical research facility in Fairfax, Northern Virginia, US, in June 2017. Thu, 29 Jun 2017 23:00:00 GMT Jinyu Bio-technology Research Facility, Kansas China's largest animal vaccine company Jinyu Bio-technology unveiled plans to establish its first US-based vaccine research lab and office facility in May 2017. Thu, 29 Jun 2017 11:46:00 GMT Abcam Global Headquarters, Cambridge Life sciences company Abcam initiated the construction of its new global headquarters building at the Cambridge Biomedical Campus (CBC) in Cambridge, UK, in June 2017. Wed, 28 Jun 2017 14:08:00 GMT